Delivery Order SPE2DB24D2018-SPE2DB24FWTH0

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $1,858.86 firm fixed price contract is for the delivery of VAXELIS vaccine syringes by February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency Troop Support Medical. The $18,323.10 firm fixed-price contract is for the provision of VAXELIS vaccine syringes (0.5 mL) with a completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which serves as a primary vehicle for supplying a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the VAXELIS vaccine. The contract has a ceiling value of $3,586.26 and is a firm fixed price delivery order. The ultimate completion date for this order is May 14, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXELIS vaccine syringes. The $3,015.25 firm fixed-price contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VAXELIS vaccine syringes. The contract has a firm fixed price of $6,155.15 and a completion date of May 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which enables the DLA to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,557.92 firm fixed price contract is for the delivery of VAXELIS vaccine syringes, with a period of performance through February 10, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VAXELIS vaccine vials (0.5 ml) to the U.S. government. The contract, with a ceiling value of $1,587.06, is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this firm fixed price contract, which does not have a set-aside designation. The company also holds...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,478.48 order is for the supply of VAXELIS vaccine syringes, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...
This delivery order contract, valued at $1,239.24, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is for the provision of VAXELIS vaccine syringes (0.5 mL) to be delivered by January 26, 2024. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $15,207.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 0.5mL VAXELIS vaccine syringes, with a performance period through November 5, 2024. This Delivery Order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB24FWTH0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,574.04 firm fixed-price contract is for the delivery of the VAXELIS vaccine in 0.5mL vials. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order does not have a set-aside designation.

Generated 10/1/24, 12:05 PM